Classical Monocyte Marker Gene Signatures (CMMGS) Identified by Analysis of Single-Cell and Bulk-RNA Sequencing to Predict Prognosis and Immunotherapy Response in Lung Adenocarcinoma

Author:

LIN HAN1,Huang Yuhan2,Ren Shencheng1,Ma Teng2,Ge Di2

Affiliation:

1. Fudan University

2. Zhongshan Hospital

Abstract

Abstract Background Classical monocytes, pivotal in the innate immune response, wield considerable influence over cancer prognosis and response to immunotherapy. Our aim was to construct lung adenocarcinoma (LUAD) prognostic signature associated with Classical monocytes.Methods This study encompassed 1,822 samples drawn from diverse public datasets. Initially, we conducted an comprehensive analysis of lung adenocarcinoma (LUAD) single-cell RNA sequencing data obtained from the Gene Expression Omnibus (GEO), identifying 145 marker genes specific to classical monocyte. Univariate Cox regression and Least Absolute Shrinkage Operator (LASSO) analyses were performed on the TCGA training cohort to construct a signature for classical monocyte marker genes.Result Patients in the TCGA LUAD cohort were categorized into high- and low-risk groups based on polygenic prognostic signature derived from these marker genes. The predictive capacity of this signature was robustly validated across distinct clinical subgroups and GEO cohorts. Notably, this signature emerged as an independent prognostic indicator via multivariate analysis. Low-risk patients exhibited heightened immune cell infiltration, correlating inversely with inflammatory activity and risk score. Conversely, the low-risk group demonstrated amplified abundance and diversity in T-cell receptor (TCR) repertoires, higher Immunophenotype scores (IPS), and lower Tumor Immune Dysfunction and Exclusion (TIDE) scores. Significantly, an assessment across three GEO immunotherapy cohorts showcased superior immunotherapeutic response and prognosis among low-risk patients compared to their high-risk counterparts.Conclusion In summary, our study introduces a novel signature rooted in monocyte marker genes that proficiently prognosticates and predicts immunotherapeutic response in LUAD patients.Supplementary Information: Supplementary information is uploaded in the attached document.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3